CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues [Abstract]
Revenues:	$ 0	$ 0	$ 0	$ 0
Expenses:
Research and development	0	0	6,150	4,830
General and administrative	69,987	66,248	228,141	291,806
Total Expenses:	69,987	66,248	234,291	296,636
Loss from operations	(69,987)	(66,248)	(234,291)	(296,636)
Interest expense, related party	(7,705)	(4,803)	(19,878)	(10,035)
Gain on loan forgiveness	0	0	0	41,600
Net loss	(77,692)	(71,051)	(254,169)	(265,071)
Preferred stock dividend	(50,411)	(50,412)	(149,590)	(149,590)
Net loss applicable to common stockholders	$ (128,103)	$ (121,463)	$ (403,759)	$ (414,661)
Basic net loss applicable to common stockholders per share	$ 0	$ 0	$ 0	$ 0
Diluted net loss applicable to common stockholders per share	$ 0	$ 0	$ 0	$ 0
Weighted average common stock shares outstanding – basic	376,858,323	376,708,894	376,858,323	376,042,025
Weighted average common stock shares outstanding – diluted	376,858,323	376,708,894	376,858,323	376,042,025